XML 53 R36.htm IDEA: XBRL DOCUMENT
v3.26.1

LOSS PER SHARE | 12 Months Ended
--- | ---
Dec. 31, 2025
LOSS PER SHARE |
LOSS PER SHARE | 29.LOSS PER SHARE A reconciliation of net loss attributable to the Company in the consolidated statements of comprehensive loss to the numerator for the computation of basic and diluted loss per share for the years ended December 31, 2023, 2024 and 2025 is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Years Ended December 31,
​ | ​ | 2023 | ​ | 2024 | ​ | 2025 | ​ | 2025
​ | ​ ​ ​ | RMB | ​ ​ ​ | RMB | ​ ​ ​ | RMB | ​ ​ ​ | US$
Net loss attributable to Concord Medical Services Holdings Limited |  | (297,658) | ​ | (308,243) | ​ | (92,811) | ​ | (13,271)
Accretion of contingently redeemable noncontrolling interests |  | — | ​ | — | ​ | — | ​ | —
Numerator for EPS computation |  | (297,658) | ​ | (308,243) | ​ | (92,811) | ​ | (13,271)
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Years Ended December 31
​ | ​ | 2023 | ​ | 2024 | ​ | 2025 | ​ | 2025
​ | ​ ​ ​ | Class A | ​ ​ ​ | Class B | ​ ​ ​ | Class A | ​ ​ ​ | Class B | ​ ​ ​ | Class A | ​ ​ ​ | Class A | ​ ​ ​ | Class B | ​ ​ ​ | Class B
​ | ​ | RMB | ​ | RMB | ​ | RMB | ​ | RMB | ​ | RMB | ​ | USD | ​ | RMB | ​ | USD
Numerator | ​ ​ ​ | ​ | ​ | ​ | ​ ​ ​ | ​ | ​ | ​ | ​ ​ ​ | ​ | ​ ​ ​ | ​ | ​ ​ ​ | ​ | ​ ​ ​ | ​
Net loss attributable to ordinary shareholders used in calculating loss per ordinary share – basic and diluted |  | (193,661) | ​ | (103,997) | ​ | (200,548) | ​ | (107,695) | ​ | (60,384) | ​ | (8,634) | ​ | (32,427) | ​ | (4,637)
Denominator: |  | ​ |  | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Weighted average number of ordinary shares outstanding used in calculating loss per share – basic and diluted |  | 85,265,910 | ​ | 45,787,948 | ​ | 85,265,910 | ​ | 45,787,948 | ​ | 85,265,910 | ​ | 85,265,910 | ​ | 45,787,948 | ​ | 45,787,948
Loss per share – basic and diluted |  | (2.27) | ​ | (2.27) | ​ | (2.35) | ​ | (2.35) | ​ | (0.71) | ​ | (0.10) | ​ | (0.71) | ​ | (0.10)
​ The effects of share options and restricted shares have been excluded from the computation of diluted loss per share for the years ended December 31, 2023, 2024 and 2025 as their effects would be anti-dilutive. In July, 2024, the Company changed the ratio of its American depositary shares (“ADSs”) to its Class A ordinary shares from one (1) ADS, representing three (3) Class A ordinary shares, to one (1) ADS representing thirty (30) Class A ordinary shares.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration